Adult extracorporeal membrane oxygenation: an international survey of transfusion and anticoagulation techniques

被引:107
作者
Esper, S. A. [1 ]
Welsby, I. J. [2 ]
Subramaniam, K. [1 ]
Wallisch, W. John [1 ]
Levy, J. H. [2 ]
Waters, J. H. [1 ]
Triulzi, D. J. [3 ]
Hayanga, J. W. A. [4 ]
Schears, G. J. [5 ]
机构
[1] Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA USA
[2] Duke Univ, Dept Anesthesiol, Durham, NC USA
[3] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA
[4] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA
[5] Mayo Clin, Dept Anesthesiol, Rochester, MN USA
关键词
anticoagulation; bleeding; cardiopulmonary bypass; extracorporeal membrane oxygenation; extracorporeal life support; thrombosis; ACTIVATED CLOTTING TIME; RECOMBINANT HUMAN ANTITHROMBIN; PARTIAL THROMBOPLASTIN TIME; HEPARIN-RESISTANT PATIENTS; TISSUE FACTOR; CARDIOPULMONARY BYPASS; COAGULATION TIME; FATAL THROMBOSIS; FACTOR-VII; MANAGEMENT;
D O I
10.1111/vox.12514
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objectivesExtracorporeal membrane oxygenation (ECMO) is a method of life support for either isolated cardiac failure or respiratory failure, with or without cardiac failure. When used for hemodynamic support, the ECMO circuit presents a non-endothelialized, artificial surface to blood inciting an inflammatory response which activates haemostatic pathways. Anticoagulation may complicate a pre-existing coagulopathy and/or inadequate surgical hemostasis of varying severity. There is no standardized method to achieve and monitor anticoagulation or guide transfusion therapy during ECMO. We tested the hypothesis that institutions across the world conduct similar management of anticoagulation and transfusion during adult ECMO support. MethodsThis is a descriptive, self-reporting cross-sectional survey of anticoagulation and transfusion practice for patients age 18 or older on ECMO. This 38 multiple-choice question survey was sent to 166 institutions, internationally, utilizing adult ECMO. About 324% (54) of institutions responded. Responses were anonymously collected. Descriptive analyses were calculated. ResultsOur findings indicate there appears to be a significant practice variation among institutions regarding anticoagulation and transfusion during adult ECMO support. DiscussionThe lack of standard practices among institutions may reflect a paucity of data regarding optimal anticoagulation and transfusion for patients requiring ECMO. Standardized protocols for anticoagulation and transfusion may help increase quality of care for and reduce morbidity, mortality and cost to patients and healthcare centres. Further study is required for standardized, high quality care.
引用
收藏
页码:443 / 452
页数:10
相关论文
共 65 条
  • [1] Use of a novel anticoagulation strategy during ECMO in a pediatric population:: Single-center experience
    Agati, Salvatore
    Ciccarello, Giuseppe
    Salvo, Dario
    Turla, Giancarlo
    Uendar, Akif
    Mignosa, Carmelo
    [J]. ASAIO JOURNAL, 2006, 52 (05) : 513 - 516
  • [2] Blood transfusion requirements and independent predictors of increased transfusion requirements among adult patients on extracorporeal membrane oxygenation - a single centre experience
    Ang, A. L.
    Teo, D.
    Lim, C. H.
    Leou, K. K.
    Tien, S. L.
    Koh, M. B. C.
    [J]. VOX SANGUINIS, 2009, 96 (01) : 34 - 43
  • [3] Ang AL, 2012, ISBT SCI SER, V7, P89
  • [4] Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass
    Avidan, MS
    Levy, JH
    van Aken, H
    Feneck, RO
    Latimer, RD
    Ott, E
    Martin, E
    Birnbaum, DE
    Bonfiglio, LJ
    Kajdasz, DK
    Despotis, GJ
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2005, 130 (01) : 107 - 113
  • [5] A phase III, double-blind, placebo-controlled, multicenter study on the efficacy of recombinant human antithrombin in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass
    Avidan, MS
    Levy, JH
    Scholz, J
    Delphin, E
    Rosseel, PMJ
    Howie, MB
    Gratz, I
    Bush, CR
    Skubas, N
    Aldea, GS
    Licina, M
    Bonfiglio, LJ
    Kajdasz, DK
    Ott, E
    Despotis, GJ
    [J]. ANESTHESIOLOGY, 2005, 102 (02) : 276 - 284
  • [6] Anticoagulation and pediatric extracorporeal membrane oxygenation: Impact of activated clotting time and heparin dose on survival
    Baird, Christopher W.
    Zurakowski, David
    Robinson, Barbara
    Gandhi, Sanjiv
    Burdis-Koch, Leighann
    Tamblyn, Joseph
    Munoz, Ricardo
    Fortich, Karol
    Pigula, Frank A.
    [J]. ANNALS OF THORACIC SURGERY, 2007, 83 (03) : 912 - 920
  • [7] Induction of monocyte tissue factor procoagulant activity during coronary artery bypass surgery is reduced with heparin-coated extracorporeal circuit
    Barstad, RM
    Ovrum, E
    Ringdal, MA
    Oystese, R
    Hamers, MJAG
    Veiby, OP
    Rolfsen, T
    Stephens, RW
    Sakariassen, KS
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 94 (03) : 517 - 525
  • [8] Variability in Anticoagulation Management of Patients on Extracorporeal Membrane Oxygenation: An International Survey
    Bembea, Melania M.
    Annich, Gail
    Rycus, Peter
    Oldenburg, Gary
    Berkowitz, Ivor
    Pronovost, Peter
    [J]. PEDIATRIC CRITICAL CARE MEDICINE, 2013, 14 (02) : E77 - E84
  • [9] BOROWIEC J, 1992, J THORAC CARDIOV SUR, V104, P642
  • [10] Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII
    Bui, JD
    Despotis, GD
    Trulock, EP
    Patterson, GA
    Goodnough, LT
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2002, 124 (04) : 852 - 854